已发表论文

miR-522-3p 通过调节葡萄糖摄取和 GLUT1 表达来促进骨肉瘤细胞生长

 

Authors Chen R, Lin J, Yan W, Chen D

Received 27 May 2019

Accepted for publication 24 September 2019

Published 1 November 2019 Volume 2019:12 Pages 9053—9058

DOI https://doi.org/10.2147/OTT.S217324

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Jyoti Bajaj

Peer reviewer comments 2

Editor who approved publication: Dr Takuya Aoki

Purpose: In a recent study, Kang et al reported a novel miRNA named miR-522-3p with critical roles in phagocytosis, in which GLUT1 played a critical role, indicating the possible interactions between them. This study aimed to investigate the role of miR-522-3p in osteosarcoma (OS).
Methods: Gene expression was analyzed by qPCR and Western blot. Overexpression experiments were performed to analyze gene interactions. Glucose uptake assay was performed to analyze the effects of glucose uptake in cells. CCK-8 assay was used to analyze cell proliferation.
Results: We found that miR-522-3p and GLUT1 were both upregulated in OS and positively correlated. Follow-up showed that high levels of miR-522-3p expression predicted poor survival. In OS cells, miR-522-3p overexpression led to upregulated GLUT1 expression and increase glucose uptake. Analysis of cell proliferation assay showed that overexpression of miR-522-3p and GLUT1 led to increased cell proliferate rates. In addition, GLUT1 siRNA silencing resulted in reduced effects of miR-522-3p overexpression.
Conclusion: MiR-522-3p promotes OS cell growth through reprogramming glucose metabolism.
Keywords: miR-522-3p, osteosarcoma, GLUT1, survival




Figure 1 miR-522-3p and GLUT1 mRNA were...